• About us
• Contact

Advertisement

Organisation › Details

Conformetrix (GB)

C4X Discovery aims to become the world’s most productive drug discovery and development Company by exploiting cutting-edge technologies to design and create best-in-class drug candidates. C4XD has a unique software platform for determining the 3D shape of drug molecules from experimental in vitro data that enables the rapid design and discovery of novel and potent drugs for diseases with high unmet medical need across broad therapeutic areas. The Company has a hybrid business model of wholly-owned programmes and partnerships with pharma, biotech and academics. The Company was founded in 2008 as a spin-out from the University of Manchester and has a highly experienced management team and Board who have delivered significant value creation within the healthcare sector historically. *

 

	Start	2008-01-01 splitoff
	Group	C4X Discovery (Group)
	Today	C4X Discovery Ltd.
	Predecessor	University of Manchester (UoM)
	Successor	C4X Discovery Ltd.
	Industry	drug discovery services
	Industry 2	NMR spectrometer
	Region	Manchester, Greater Manchester
	Country	United Kingdom (GB)
	City	n. a.
		Address record changed: 2022-08-05
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2023-07-10

Advertisement

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.